Webwire iconWebwireSep 22, 2026

OneSkin Introduces a New Approach to Rich Creams, Designed for Skin Longevity

Powered by OneSkin's proprietary OS-01 Peptideв„ў and a Dual-Phase Hydration System, OS-01 FACE RICH CREAM works at the structural level, restoring skin's firmness, resilience and capacity to hold onto hydration long-term..

OneSkin Introduces a New Approach to Rich Creams, Designed for Skin Longevity

Share this story

Send the public story page.

Useful takeaways from this story.

Powered by OneSkin's proprietary OS-01 Peptideв„ў and a Dual-Phase Hydration System, OS-01 FACE RICH CREAM works at the structural level, restoring skin's firmness, resilience and capacity to hold onto...

OneSkin, the skin longevity company behind the first peptide proven to reverse skin's biological age, today launched OS-01 FACE RICH CREAM, a first-of-its-kind formula engineered to address the biological...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=360792

Building the complete brief

The page is ready to read now. The fuller skim-friendly version will appear here automatically.

The useful part

Powered by OneSkin's proprietary OS-01 Peptideв„ў and a Dual-Phase Hydration System, OS-01 FACE RICH CREAM works at the structural level, restoring skin's firmness, resilience and capacity to hold onto hydration long-term.. OneSkin, the skin longevity company behind the first peptide proven to reverse skin's biological age, today launched OS-01 FACE RICH CREAM, a first-of-its-kind formula engineered to address the biological changes that drive age-related moisture loss. Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=360792

Details worth keeping

OneSkin, the skin longevity company behind the first peptide proven to reverse skin's biological age, today launched OS-01 FACE RICH CREAM, a first-of-its-kind formula engineered to address the biological changes that drive age-related moisture loss. Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=360792

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app